Skip to content

Plasma levobipivacaine concentration after abdominal block

Plasma levobipivacaine concentration after abdominal block - Plasma levobipivacaine concentration after abdominal block

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-jRCT1090220224
Enrollment
36
Registered
2015-10-06
Start date
2015-10-06
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colon carcinoma

Interventions

Intervention type: Name of intervention: Dose form / Japanese Medical Device Nomenclature: Route of administration / Site of application: Dose per administration: Dosing frequency / Frequency of use:

Sponsors

Nakajima Kunie
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: over 20 years old and scheduled for mid-line incision surgery of laparoscopic colectomy were recruited at Gunma University Hospital.

Exclusion criteria

Exclusion criteria: 1)patient who did not have the block 2)patient who had an allergy to local anesthetics 3)patient who refused to join the study 4)patient who was judged as inadequite

Design outcomes

Primary

MeasureTime frame
plasma concentraiton of levobupivacaine

Secondary

MeasureTime frame
pain intensity

Countries

Japan

Contacts

Public ContactNakajima Kunie

Gunma University Hospital

knkunie@yahoo.co.jp+81-27-220-8454

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026